Front Microbiol. 2015 Nov 13;6:1281. doi: 10.3389/fmicb.2015.01281. eCollection 2015.
Antimicrobial and Anti-Virulence Activity of Capsaicin Against Erythromycin-Resistant, Cell-Invasive Group A Streptococci.
Frontiers in microbiology
Emanuela Marini, Gloria Magi, Marina Mingoia, Armanda Pugnaloni, Bruna Facinelli
Affiliations
Affiliations
- Unit of Microbiology, Department of Biomedical Sciences and Public Health, Polytechnic University of Marche , Ancona, Italy.
- Department of Clinical and Molecular Sciences, Polytechnic University of Marche , Ancona, Italy.
PMID: 26617603
PMCID: PMC4643145 DOI: 10.3389/fmicb.2015.01281
Abstract
Capsaicin (8-methyl-N-vanillyl-6-nonenamide) is the active component of Capsicum plants (chili peppers), which are grown as food and for medicinal purposes since ancient times, and is responsible for the pungency of their fruit. Besides its multiple pharmacological and physiological properties (pain relief, cancer prevention, and beneficial cardiovascular, and gastrointestinal effects) capsaicin has recently attracted considerable attention because of its antimicrobial and anti-virulence activity. This is the first study of its in vitro antibacterial and anti-virulence activity against Streptococcus pyogenes (Group A streptococci, GAS), a major human pathogen. The test strains were previously characterized, erythromycin-susceptible (n = 5) and erythromycin-resistant (n = 27), cell-invasive pharyngeal isolates. The MICs of capsaicin were 64-128 μg/mL (the most common MIC was 128 μg/mL). The action of capsaicin was bactericidal, as suggested by MBC values that were equal or close to the MICs, and by early detection of dead cells in the live/dead assay. No capsaicin-resistant mutants were obtained in single-step resistance selection studies. Interestingly, growth in presence of sublethal capsaicin concentrations induced an increase in biofilm production (p ≤ 0.05) and in the number of bacteria adhering to A549 monolayers, and a reduction in cell-invasiveness and haemolytic activity (both p ≤ 0.05). Cell invasiveness fell so dramatically that a highly invasive strain became non-invasive. The dose-response relationship, characterized by opposite effects of low and high capsaicin doses, suggests a hormetic response. The present study documents that capsaicin has promising bactericidal activity against erythromycin-resistant, cell-invasive pharyngeal GAS isolates. The fact that sublethal concentrations inhibited cell invasion and reduced haemolytic activity, two important virulence traits of GAS, is also interesting, considering that cell-invasive, erythromycinresistant strains can evade β-lactams by virtue of intracellular location and macrolides by virtue of resistance, thus escaping antibiotic treatment. By inhibiting intracellular invasion and haemolytic activity, capsaicin could thus prevent both formation of a difficult to eradicate intracellular reservoir, and infection spread to deep tissues.
Keywords: Group A streptococci; biofilm; capsaicin; cell invasion; haemolytic activity; hormesis; virulence
References
- J Biol Chem. 2011 Jan 28;286(4):2750-61 - PubMed
- Adv Exp Med Biol. 2008;609:29-42 - PubMed
- Lancet Infect Dis. 2003 Apr;3(4):191-200 - PubMed
- Curr Opin Microbiol. 2006 Oct;9(5):445-53 - PubMed
- Cell. 2006 Feb 24;124(4):715-27 - PubMed
- Microbiology. 1998 Jan;144 ( Pt 1):109-18 - PubMed
- Bull N Y Acad Med. 1975 Oct;51(9):1046-55 - PubMed
- Environ Toxicol. 2005 Oct;20(5):467-74 - PubMed
- J Med Microbiol. 2004 Oct;53(Pt 10):1023-7 - PubMed
- J Clin Microbiol. 1985 Dec;22(6):996-1006 - PubMed
- Diagn Microbiol Infect Dis. 2009 May;64(1):52-6 - PubMed
- Clin Infect Dis. 2005 Sep 1;41(5):609-11 - PubMed
- J Clin Microbiol. 2004 Feb;42(2):639-44 - PubMed
- Pediatrics. 2012 Mar;129(3):e798-802 - PubMed
- Gastroenterology. 1998 Dec;115(6):1405-13 - PubMed
- Lancet. 1998 Dec 19-26;352(9145):1954-6 - PubMed
- Front Cell Infect Microbiol. 2015 Feb 11;5:15 - PubMed
- Antimicrob Agents Chemother. 2002 Dec;46(12):3750-5 - PubMed
- Int J Toxicol. 2010 May-Jun;29(3):235-46 - PubMed
- Int J Artif Organs. 2011 Sep;34(9):737-51 - PubMed
- J Clin Microbiol. 2006 Aug;44(8):2721-7 - PubMed
- Eur J Pharmacol. 2011 Jan 10;650(1):1-7 - PubMed
- J Antimicrob Chemother. 2012 Oct;67(10):2401-8 - PubMed
- Eur J Clin Microbiol Infect Dis. 2014 Feb;33(2):211-9 - PubMed
- PLoS One. 2012;7(3):e33032 - PubMed
- Front Microbiol. 2015 Mar 03;6:165 - PubMed
- FEMS Microbiol Lett. 2010 May;306(1):54-60 - PubMed
- Lancet. 2001 Jul 7;358(9275):30-3 - PubMed
- J Med Microbiol. 2012 Jul;61(Pt 7):975-83 - PubMed
- Front Microbiol. 2012 Jan 25;3:12 - PubMed
- J Microbiol Methods. 2000 Apr;40(2):175-9 - PubMed
- Nat Rev Microbiol. 2014 Jul;12(7):465-78 - PubMed
- Clin Infect Dis. 1999 Oct;29(4):869-73 - PubMed
- Clin Microbiol Rev. 1999 Oct;12(4):564-82 - PubMed
- J Ethnopharmacol. 1996 Jun;52(2):61-70 - PubMed
- Pediatr Infect Dis J. 2006 Oct;25(10):880-3 - PubMed
- Molecules. 2014 Apr 24;19(4):5434-47 - PubMed
- Environ Sci Technol. 2013 Dec 3;47(23):13772-80 - PubMed
- Pest Manag Sci. 2003 Sep;59(9):1007-15 - PubMed
- Phytomedicine. 2008 Aug;15(8):639-52 - PubMed
Publication Types